Vulnerable populations, including racial and ethnic minority groups and individuals with low socioeconomic status, are underrepresented in clinical trials and biobanking. Focus groups among vulnerable populations found they were interested in participating in clinical trials, but lacked information and faced other barriers precluding their participation. (cure)